Charcot-Marie-Tooth disease X-linked recessive 2

disease
On this page

Also known as Charcot Marie Tooth disease X-linked recessive 2Charcot-Marie-Tooth disease X-linked recessive type 2Charcot-Marie-Tooth disease, X-linked recessive, 2Charcot-Marie-Tooth neuropathy, X-linked recessive, 2Charcot-Marie-Tooth neuropathy, X-linked recessive, 2, X-linked recessiveCMTX 2CMTX2X-linked Charcot-Marie-Tooth disease type 2

Summary

Charcot-Marie-Tooth disease X-linked recessive 2 (MONDO:0010550) is a disease. A subtype of Charcot-Marie-Tooth disease type X — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 26

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families5WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

26 HPO clinical features (Orphanet curated; top 26 by frequency):

HPO IDTermFrequency
HP:0001284AreflexiaFrequent (30-79%)
HP:0001288Gait disturbanceFrequent (30-79%)
HP:0001761Pes cavusFrequent (30-79%)
HP:0002378Hand tremorFrequent (30-79%)
HP:0002936Distal sensory impairmentFrequent (30-79%)
HP:0003376Steppage gaitFrequent (30-79%)
HP:0003431Decreased motor nerve conduction velocityFrequent (30-79%)
HP:0003444EMG: chronic denervation signsFrequent (30-79%)
HP:0008944Distal lower limb amyotrophyFrequent (30-79%)
HP:0008954Intrinsic hand muscle atrophyFrequent (30-79%)
HP:0009027Foot dorsiflexor weaknessFrequent (30-79%)
HP:0009053Distal lower limb muscle weaknessFrequent (30-79%)
HP:0011399Tibialis atrophyFrequent (30-79%)
HP:0011727Peroneal muscle weaknessFrequent (30-79%)
HP:0030237Hand muscle weaknessFrequent (30-79%)
HP:0000407Sensorineural hearing impairmentOccasional (5-29%)
HP:0000543Optic disc pallorOccasional (5-29%)
HP:0001138Optic neuropathyOccasional (5-29%)
HP:0001249Intellectual disabilityOccasional (5-29%)
HP:0001265HyporeflexiaOccasional (5-29%)
HP:0001347HyperreflexiaOccasional (5-29%)
HP:0002313Spastic paraparesisOccasional (5-29%)
HP:0003487Babinski signOccasional (5-29%)
HP:0006801Hyperactive deep tendon reflexesOccasional (5-29%)
HP:0007924Slow decrease in visual acuityOccasional (5-29%)
HP:0031866Clasp-knife signOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical nameCharcot-Marie-Tooth disease X-linked recessive 2
Mondo IDMONDO:0010550
MeSHC535302
OMIM302801
Orphanet101076
DOIDDOID:0110208
SNOMED CT763457000
UMLSC1844873
MedGen336803
GARD0001243
Is cancer (heuristic)no

Also known as: Charcot Marie Tooth disease X-linked recessive 2 · Charcot-Marie-Tooth disease X-linked recessive type 2 · Charcot-Marie-Tooth disease, X-linked recessive, 2 · Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 · Charcot-Marie-Tooth neuropathy, X-linked recessive, 2, X-linked recessive · CMTX 2 · CMTX2 · X-linked Charcot-Marie-Tooth disease type 2

Disease family

This is a subtype of Charcot-Marie-Tooth disease type X. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseX-linked diseaseCharcot-Marie-Tooth disease type XCharcot-Marie-Tooth disease X-linked recessive 2

Related subtypes (5): Charcot-Marie-Tooth disease X-linked dominant 6, Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked recessive 3, Charcot-Marie-Tooth disease X-linked recessive 4, Charcot-Marie-Tooth disease X-linked recessive 5

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.